SCHEMBL932339

SCHEMBL932339

C=CCN(CC=C)c1ccc(F)c(C2(C3CC3)N=C(C)C(N)=N2)c1

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.39
KCNH2 Q12809 5/20 0.39
BACE2 Q9Y5Z0 3/20 0.39
APP P05067 9/20 0.32
UTS2R Q9UKP6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL944533 0.74
SCHEMBL932487 0.64 BACE1 (0.60) BACE1BACE2APP
SCHEMBL8524528 0.63 ALDH1A1 (0.42)
SCHEMBL6580919 0.62 S100B (0.62) UTS2R
SCHEMBL19886355 0.62 UTS2R (0.35) UTS2R
SCHEMBL931680 0.60 PTPN1 (0.31)
SCHEMBL931600 0.58 BACE1 (0.55) BACE1KCNH2BACE2APP
SCHEMBL851567 0.58 CHKA (0.50)
SCHEMBL249284 0.57 CRHR1 (0.39) KCNH2UTS2R
SCHEMBL544100 0.57 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed